For Healthcare Professionals

China Alair System Registry Study-CARE Study

clipboard-pencil

About the study

The objective of this Registry is to collect real-world outcome data for bronchial thermoplasty (BT) procedures in patients with severe persistent asthma who remain symptomatic despite taking standard of care maintenance medications.
user-3

Who can take part

You may be eligible to participate in the study if you meet the following criteria:

INCLUSION CRITERIA

  1. Patient is an adult aged 18 years or older with severe persistent asthma who remains symptomatic despite taking standard of care maintenance medications.
  2. Patient is able to read, understand, and sign a written Informed Consent to participate in the Registry and able to comply with the study requirements.
  3. Patient is able to undergo bronchoscopy in the opinion of the Investigator or per hospital guidelines and as described in the Alair System Directions for Use (DFU).

EXCLUSION CRITERIA

  1. Patient has an implanted electrical stimulation device (e.g., a pacemaker, cardiac defibrillator, or deep nerve or deep brain stimulator).
  2. Patient has any other medical condition that would make them inappropriate for study participation, in the Investigator's opinion.
pin location

Study Locations

Enter your ZIP code/Postal code/PIN code to locate study sites near you:

How to Apply


Contact the study center to learn if this study is a good match for you.
Phone iconCall 8610 85742906Email iconEmail Study Center

Study’s details


Contition

Asthma

Age

18+

Phase

N/A

Participants needed

225

Est. Completion Date

Jun 2019

Treatment type

Observational [Patient Registry]


Sponsor

BSC International Medical Trading (Shanghai) Co., Ltd.

ClinicalTrials.gov identifier

NCT02206269

Study number

E7100

Understanding Clinical Trials


Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?
Vector

Interested?

Sign up to save your favorites, 
receive newsletters, resources, and alerts 
about clinical trials related to your conditions of interest.